SARS-CoV-2 recombinant spike protein nanoparticle vaccine (rS), monovalent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2 recombinant spike protein nanoparticle vaccine (rS), monovalent, covering 2024-12-13 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines [Phase 2, Phase 3]